Patient handout: Should I have ultrasound and cfDNA testing?

A new study finds women with postpartum hemorrhage face significantly higher odds of cardiovascular disease and thromboembolism for up to 15 years after childbirth.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

Women with attention-deficit hyperactivity disorder are over 3 times more likely to experience premenstrual dysphoric disorder, especially when co-occurring with anxiety or depression, according to new research.

April is STI Awareness Month, and as such, we are focusing on testing and increase of STDs in the pandemic, especially how women and minorities are affected.

A major clinical trial shows personalized treatment based on molecular profiling can safely cut radiation use in nearly half of women with high-intermediate risk endometrial cancer.

A new study finds that exposure to mycoestrogens during pregnancy may reduce birthweight and impair placental efficiency, with climate change expected to increase exposure risks.